迪瑞医疗收盘下跌2.68%，滚动市盈率113.42倍，总市值40.61亿元

Company Overview - Dirui Medical's closing price on August 14 was 14.89 yuan, down 2.68%, with a rolling PE ratio of 113.42 times and a total market value of 4.061 billion yuan [1] - The company operates in the medical device industry, which has an average PE ratio of 55.76 times and a median of 39.14 times, placing Dirui Medical at the 106th position in the industry ranking [1] - As of March 31, 2025, Dirui Medical had 17,877 shareholders, a decrease of 209 from the previous period, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Business Operations - Dirui Medical specializes in the research, development, production, marketing, and service of medical testing instruments and related reagents [1] - The main products include urine analysis, biochemical analysis, chemiluminescence immunoassay, gynecological secretion analysis, blood cell analysis, coagulation analysis, and overall laboratory solutions [1] - The company holds 213 patents, including 136 invention patents, and has obtained 96 software copyrights [1] Financial Performance - In the latest quarterly report for Q1 2025, Dirui Medical reported revenue of 182 million yuan, a year-on-year decrease of 72.47%, and a net profit of 15.68 million yuan, down 87.13% year-on-year, with a gross profit margin of 42.78% [1]